Lisdexamfetamine
Vyvanse (lisdexamfetamine) is a prescription central nervous system stimulant used to treat attention-deficit/hyperactivity disorder (ADHD) in patients 6 years and older, as well as moderate-to-severe binge eating disorder in adults. As a prodrug, it is converted in the body to dextroamphetamine, which increases levels of certain brain chemicals to improve focus, attention, and impulse control. Due to its stimulant properties and potential for dependence, it is classified as a Schedule II controlled substance.
Vyvanse is a prescription stimulant medication used to treat ADHD and binge eating disorder, working by increasing brain chemicals that affect attention and impulse control.
Key facts at a glance
- RxNorm
- 711043
- Generic
- Vyvanse
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Vyvanse is FDA-approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children (ages 6+), adolescents, and adults, as well as for the treatment of moderate-to-severe binge eating disorder in adults.
Vyvanse is a prodrug that converts to dextroamphetamine in the body. It works by increasing the release and blocking the reuptake of the neurotransmitters norepinephrine and dopamine in the brain, which helps improve attention, focus, and impulse control.
Vyvanse is a Schedule II controlled substance with high abuse potential and risk of dependence. Common side effects include decreased appetite, weight loss, insomnia, dry mouth, and increased heart rate or blood pressure. It should not be used in patients with certain heart conditions, hyperthyroidism, or those taking MAO inhibitors. Requires prescription and regular monitoring by a healthcare provider.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy